Comprehensive reassessment of plasma VEGFA (pVEGFA) as a candidate predictive biomarker for bevacizumab (Bv) in 13 pivotal trials (seven indications).
Carlos Bais
Employment or Leadership Position - Roche/Genentech
Research Funding - Roche/Genentech
Christina Rabe
Employment or Leadership Position - Roche
Norbert Wild
Employment or Leadership Position - Roche
Magdalena Swiatek-de Lange
Employment or Leadership Position - Roche
David Chen
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Kyu Hong
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Lukas Amler
Employment or Leadership Position - Genentech
Nicola Moore
Employment or Leadership Position - Roche
Priti S. Hegde
Employment or Leadership Position - Genentech